The Mesothelioma Guide Blog

This post was updated May 17, 2022: O-I Glass received court approval from a bankruptcy court in Delaware to move forward with its $610 million asbestos trust fund. This fund will...

The newest type of radiation therapy is proton beam radiation therapy, often shortened to proton radiation. It’s also growing in popularity for use treating a number of...

One of the concerns for some people with cancer is whether COVID-19 vaccinations would work during cancer treatment. Would the combination of the two offset each other or make the...

The United States Food and Drug Administration (FDA) issued a world-changing proposal that could significantly reduce the number of cancer cases in the coming years. The FDA...

A recent study shows any type of surgery combined with hyperthermic intrathoracic chemotherapy (HITHOC) results in improved disease-free intervals and overall survival rates for...

A phase 2 clinical trial testing anetumab ravtansine against the chemotherapy drug vinorelbine did not provide the results investigators hoped for mesothelioma. Anetumab...

According to clinical trial Checkmate 743, mesothelioma immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy), when taken together, result in a higher quality of life...

Mesothelioma specialist Dr. Joseph Friedberg was appointed the new Thoracic Surgeon-in-Chief of Temple University Health System and the affiliated Fox Chase Cancer Center. He will...

The Environmental Protection Agency (EPA) is proposing a ban of chrysotile asbestos, which the agency said is the only type of asbestos still imported to the United States. This...